by RIVANNA | Sep 22, 2026 | Press Releases
100+ patents across 20+ families, accelerating at 30% year-over-year growth CHARLOTTESVILLE, VA, SEPTEMBER 22, 2026: RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced its 100th patent filing: an AI-powered ultrasound pathology...
by RIVANNA | Sep 16, 2026 | Press Releases
Effective October 1, 2026, ICD-10-PCS code XEZU3HC establishes the first dedicated national inpatient coding category for real-time ultrasound navigation with continuous needle tracking. CHARLOTTESVILLE, VA, SEPTEMBER 17, 2026: RIVANNA®, developer of AI-enabled...
by RIVANNA | Jul 15, 2026 | News
Neuraxial Anesthesia · Inflection Point The Inflection Point for Neuraxial Guidance Why Real-Time Ultrasound Is Finally Here The inflection point is not approaching. It is here. RIVANNA Insight Reviewed by Brandon Togioka, MD, Oregon Health & Science University Based...
by RIVANNA | Jun 25, 2026 | News
RIVANNA® Co-founder and CEO Will Mauldin, PhD, joined Outcomes Rocket, a healthcare leadership podcast, for a conversation recorded at DeviceTalks Boston, an annual medical device conference. Released June 23, 2026, the episode covers RIVANNA’s clinical...
by RIVANNA | May 7, 2026 | Press Releases
CHARLOTTESVILLE, VA – MAY 7, 2026 – RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro® XV diagnostic ultrasound system. The clearance...
